companies: 6,640     total market cap: $101.03 T
Larimar Therapeutics, Inc.
LRMR

$424.31 M
Marketcap
$6.65
Share price
US
Country
$0.13
Change (1 day)
$13.68
Year High
$2.18
Year Low
Biotechnology
Categories

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

marketcap

Stock price history for Larimar Therapeutics, Inc. (LRMR)

Highest end of day price: $616.08 USD on 2015-03-19

Lowest end of day price: $1.53 USD on 2022-08-05

Stock price history of Larimar Therapeutics, Inc. from 2014 to 2024


What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools